Pharma and IT funds

Pharma and IT funds: The year 2020 was memorable for the stock market in many ways. This year tested the patience and patience of investors and achieved new record levels in just nine months after the historic decline.

During this period, silver was invested in pharma, healthcare, technology and international stocks. ETIG figures show that 18 funds investing in these categories gave more than 50 per cent to investors and five of which gave more than 70 per cent. This year, the Nifty has gained about 15 percent.

Wealth managers said the market’s eye on pharma and technology stocks had been on hold since March 24, when the market indicated a comeback. Due to Corona virus, all the sectors were badly affected, but these sectors benefited immensely.

Harshvardhan Roongta, CFP of Rungta Securities, said, “The demand for health products increased among the people after the corona virus. Along with the rapid acceptance of technology, work from home and the trend of automation has increased interest in IT companies.”

International funds invested in foreign markets, which also benefited investors. Many disappointed investors turned to foreign funds, which gave them good returns. Like the Indian market, the American markets also made a strong comeback.

Many midcap and smallcap funds also took advantage of the market boom and gave very good returns to investors. Generally, the asset under management of these funds is slightly less.

Pharma and IT funds

Read this too:

Financial & Business News – CapitalBoat
CapitalBoat provides the latest stock market, financial and business news. Get stock market quotes, personal financial advice, corporate news, Startup stories and latest updates on Economy & Politics, Personal Finance on your Whats app.
Get Breaking News Notifications Via Whats app.
Join our whats app newsletter using this invite link. Click on the link to open chat and send message ‘START’ to join us.

Leave a Reply

Your email address will not be published. Required fields are marked *